19 Feb, 13 | by BMJ Group
In the UK, it is estimated that 24% of HIV positive patients are unaware of their infection. This figure is derived from statistical modelling, but how often do people who are identified as having been unaware of their infection are actually just non-disclosing instead? In this podcast Gary Brooks talks to Ann Sullivan from Chelsea and Westminster Hospital NHS Foundation Trust, about her research into this phenomenon.
Read the full paper online.
Non disclosure of HIV status in the clinic [17:14m]:
The 2008 UK National Guidelines for HIV testing recommended HIV testing should be offered to all general medical admissions aged 16–60 years in high prevalence areas, and that this should be evaluated to ensure this was effective in diagnosing previously undiagnosed HIV. In this podcast, Gary Brook talks to Adrian Palfreeman, University Hospitals Leicester, about his evaluation in the city.
See also:
HIV testing for acute medical admissions: evaluation of a pilot study in Leicester, England
Routine HIV testing for acute medical admissions:
Katy Turner (NIHR research fellow, School of Social and Community Medicine, Bristol University) talks to Elizabeth Carlin (consultant in Genitourinary Medicine, Nottingham University Hospitals) about the possibilities, limitations and practicalities of using recent infection testing algorithm (RITA) tests to detect HIV.
See also:
Using recent infection testing algorithm tests in clinical practice
Recent infection testing algorithm (RITA) tests for HIV [16:38m]:
13 Jun, 12 | by BMJ Group
Peter Greenhouse (consultant in sexual health at Bristol Sexual Health Centre and Western) talks to Christopher Carne (consultant in the Department of Genitourinary Medicine, Addenbrookes Hospital, Cambridge University) about his recent case-controlled study looking at semen abnormalities in genitourinary medicine clinic attendees.
See also:
Low sperm counts in genitourinary medicine clinic attendees: results from a case–control study
Low sperm counts in genitourinary medicine clinic attendees [13:40m]:
William Wong (Department of Family Medicine and Primary Care, The University of Hong Kong, Hong Kong, China) and Till Bärnighausen (Department of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, USA) discuss March’s STI HIV/AIDS themed issue.
They talk about patient perspectives of ART, the future of providing treatment in different countries and contexts, and political and donor commitment to treating the disease.
Read all of the papers in the special issue online.
HIV/AIDS today and tomorrow [23:49m]:
Dr Alan Tang from Royal Berkshire NHS Foundation Trust, discusses approaches to setting up and running a prison based sexual health service with Éamonn O’Moore, unit director for Thames Valley Health Protection Unit of the HPA.
See also:
Review: How to run a prison sexually transmitted infection service
Running a prison sexual health service in the UK [50:54m]:
13 Jan, 12 | by BMJ Group
King Holmes (director, Center for AIDS and STD, University of Washington; past president of the IUSTI) talks to Patricia Garcia (dean of the School of Public Health, Universidad Peruana Cayetano Heredia, Peru; regional director for IUSTI in Latin America and the Carribbean) about the progress in treating STIs in Latin America and the Caribbean.
Professor Garcia discusses what a recent survey by The Latin American and Caribbean Association for the Control of Sexually Transmitted Infections (ALAC-ITS) revealed about STI programmes in the region, including rapid needle testing in Brazil and Peru’s national AIDS STI programme.
See also:
STI management and control in Latin America: where do we stand and where do we go from here?
STI supplement: Global Sexual Health: prioritising the challenges and identifying the solutions
STI programmes in Latin Americ and the Caribbean [17:58m]:
15 Nov, 11 | by BMJ Group
Dr Colm O’Mahony (consultant at the Countess of Chester Hospital NHS Foundation Trust, UK) talks to Professor Christopher Fairley (director of the Melbourne Sexual Health Centre, University of Melbourne, Australia) about the near disappearance of genital warts in Australia’s young women following the start of their human papillomavirus (HPV) vaccination programme.
They also discuss the UK’s decision to provide Cervarix, rather than Gardasil, through its HPV programme.
See also:
The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme
Australia's HPV vaccination programme and disappearing genital warts [13:34m]:
Catherine Ison and Gwenda Hughes, Health Protection Agency UK, and Craig Tipple, Imperial College London, discuss strategies for the surveillance and treatment of antibiotic resistance bacteria.
See also:
High prevalence of macrolide resistant Treponema pallidum strains in a London centre
Surveillance and treatment of antibiotic resistance [19:43m]:
Michael Waugh discusses with David Goldmeier how to recognise sexual addiction in the sexual health clinic.
See also:
How to recognise sexual addiction in the sexual health clinic setting?
Recognising sexual addiction. [13:57m]: